Category: Consumer goods
Quick infos Headquarters: California, United States Trade prices Volume: Market Cap: 1.91B Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: November 24, 2020
Earnings History Date EPS / Forecast Revenue / Forecast May 10, 2021 March 17, 2021 November 24, 2020 -0.2 / -0.1968.00K / 34KBeat! November 10, 2020 -0.2 / -0.1968K / 34KBeat! August 10, 2020 -0.2 / -0.19500 / 7.5KBeat! view more
Historical Data Date Price Open High Low Vol Change ER Jan 13, 2021 14.78 16.24 16.40
14.40
2.04M -7.57% Jan 12, 2021 15.99 14.40 16.05
14.40
1.42M 11.51% Jan 11, 2021 14.34 14.27 14.77
13.89
927.19K 0.49% Jan 8, 2021 14.27 14.26 14.90
13.65
1.47M 0.78% Jan 7, 2021 14.16 12.82 14.19
12.60
1.30M 10.37% Jan 6, 2021 12.83 12.90 13.42
12.54
1.39M -0.54% Jan 5, 2021 12.90 13.51 13.79
12.61
1.51M -6.05% Jan 4, 2021 13.73 13.18 14.80
12.61
3.10M 3% Dec 31, 2020 13.33 14.59 14.74
12.97
2.28M -7.17% Dec 30, 2020 14.36 13.55 15.47
13.32
2.12M 7.32% view more
News
ImmunityBios hAd5 COVID-19 Vaccine Candidate Stimulates Memory T-Cell Recall in Patients Infected with SARS-CoV-2 finance.yahoo.com Nov 28, 2020 9:00 am
ImmunityBio Announces Publication of Preclinical Data Demonstrating IL-15 Superagonist N-803 Improves Natural Killer-Mediated Tumor Cell Killing finance.yahoo.com Nov 23, 2020 9:00 am ImmunityBio COVID-19 vaccine shows favorable safety profile in early-stage study seekingalpha.com Nov 10, 2020 8:36 pm
ImmunityBio, NantKwest Announce Positive Interim Phase 1 Safety Data of hAd5 COVID-19 Vaccine Dose Study finance.yahoo.com Nov 10, 2020 7:00 am Second tier COVID-19 vaccine developers under pressure on positive Pfizer/BioNTech data seekingalpha.com Nov 10, 2020 1:04 am NantKwest names new CEO seekingalpha.com Oct 27, 2020 4:35 am
ImmunityBio, NantKwest Announce First Patient Dosed in Phase 1 Clinical Trial of Second-Generation COVID-19 Vaccine Candidate Delivering Both Spike and Nucleocapsid of SARS-CoV-2 finance.yahoo.com Oct 21, 2020 5:06 pm
NantKwest, ImmunityBio Add Third-Line Cohort to Phase 2 Pancreatic Cancer Trial; Opens Study to Patients Who Have Failed All Approved Standards of Care finance.yahoo.com Oct 6, 2020 4:05 pm
NantKwest to Present at the 7th Annual Jefferies Cell Therapy Summit finance.yahoo.com Sep 21, 2020 9:00 am
NantKwest and ImmunityBio Sign Collaboration Agreement for Joint Development, Manufacturing, Marketing, and Commercialization of COVID-19 Vaccine and Related Therapeutics finance.yahoo.com Aug 24, 2020 9:00 am Rockville biotech founded by L.A. billionaire to lay off 52 bizjournals.com Aug 11, 2020 2:49 pm
Healthcare Stocks are Gaining Ground in Technology Niche: Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI), Inovalon Holdings, NantKwest Inc. finance.yahoo.com Aug 11, 2020 10:20 am
NantKwest and ImmunityBio Announce Therapeutics and Vaccines for Combatting COVID-19; Clinical Trials Anticipated to Begin This Quarter finance.yahoo.com Aug 11, 2020 8:30 am
NantKwest to Present and Provide Update at Upcoming Jefferies 2019 Annual Healthcare Conference finance.yahoo.com Aug 11, 2020 8:00 am NantKwest in Pact with Generate Life’s CBR on potential COVID-19 treatment seekingalpha.com Aug 11, 2020 1:50 am NantKwest prices $80M equity offering seekingalpha.com Jun 25, 2020 3:59 pm NantKwest readies equity raise seekingalpha.com Jun 25, 2020 6:08 am NantKwest initiates early-stage study for COVID-19 vaccine candidate seekingalpha.com Oct 22, 2020 7:39 pm NantKwest/ImmunityBio on go with study of human adenovirus vaccine in COVID-19 seekingalpha.com Oct 15, 2020 7:40 pm NantKwest/ImmunityBio expand mid-stage pancreatic cancer study seekingalpha.com Oct 7, 2020 4:27 am Talk about NantKwest Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!
